Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( <scp>GLP</scp> ‐1‐ <scp>RAs</scp> ) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study
The study protocol was pre-registered at the Center for Open Science's Real-World Evidence Registry and is publicly accessible online (https://doi.org/10.17605/OSF.IO/PSY74).
Authors
- Sarah R. Hoffman (ORCID: https://orcid.org/0000-0001-5629-160X)
- Stephan Lanes (ORCID: https://orcid.org/0000-0001-9536-6643)
- Vincent J. Willey (ORCID: https://orcid.org/0000-0002-6473-6469)
- Matthew J. Crowley (ORCID: https://orcid.org/0000-0002-6205-4536)
- Anahit Papazian
- Jeff White (ORCID: https://orcid.org/0000-0002-0277-5921)
- V.L. Fisher
- Mark J. Cziraky
- Tracey Quimbo
Institutions
- Morristown Medical Center (US)
- Duke Medical Center (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/pds.70214
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29